CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: beryllium(2+)
Accession: CHEBI:30502
browse the term
Definition: A beryllium cation that has formula Be.
Synonyms: exact_synonym: beryllium(2+) ion; beryllium(II) cation
related_synonym: Be(2+); Formula=Be; InChI=1S/Be/q+2; InChIKey=PWOSZCQLSAMRQW-UHFFFAOYSA-N; SMILES=[Be++]
xref: CAS:22537-20-8; Gmelin:6849
xref_mesh: MESH:D001608
G
ACSL4
acyl-CoA synthetase long chain family member 4
increases expression multiple interactions
EXP
beryllium sulfate results in increased expression of ACSL4 mRNA [sodium bisulfide results in increased abundance of Hydrogen Sulfide] inhibits the reaction [beryllium sulfate results in increased expression of ACSL4 mRNA]; Deferoxamine inhibits the reaction [beryllium sulfate results in increased expression of ACSL4 mRNA]; NCOA4 protein affects the reaction [beryllium sulfate results in increased expression of ACSL4 mRNA]
CTD
PMID:36843388
NCBI chr X:109,641,335...109,733,257
Ensembl chr X:109,624,244...109,733,403
G
ACTA2
actin alpha 2, smooth muscle
increases expression
EXP
beryllium sulfate results in increased expression of ACTA2 mRNA
CTD
PMID:16314022
NCBI chr10:88,935,074...88,991,337
Ensembl chr10:88,935,074...88,991,339
G
AMOT
angiomotin
decreases expression
EXP
beryllium sulfate results in decreased expression of AMOT mRNA
CTD
PMID:35679967
NCBI chr X:112,774,877...112,840,831
Ensembl chr X:112,774,503...112,840,831
G
ANXA5
annexin A5
increases expression
EXP
beryllium sulfate results in increased expression of ANXA5 mRNA
CTD
PMID:16314022
NCBI chr 4:121,667,946...121,696,980
Ensembl chr 4:121,667,946...121,696,995
G
ARHGAP26
Rho GTPase activating protein 26
increases expression decreases expression
EXP
beryllium sulfate results in increased expression of ARHGAP26 mRNA beryllium sulfate results in decreased expression of ARHGAP26 mRNA
CTD
PMID:35679967
NCBI chr 5:142,770,377...143,229,011
Ensembl chr 5:142,770,377...143,229,011
G
CCL3
C-C motif chemokine ligand 3
multiple interactions increases secretion
EXP
beryllium sulfate promotes the reaction [RUNX1 protein binds to CCL3 promoter] beryllium sulfate results in increased secretion of CCL3 mRNA
CTD
PMID:16314022
NCBI chr17:36,088,256...36,090,143
Ensembl chr17:36,088,256...36,090,169
G
CCL4
C-C motif chemokine ligand 4
increases secretion
EXP
beryllium sulfate results in increased secretion of CCL4 mRNA
CTD
PMID:16314022
NCBI chr17:36,103,827...36,105,614
Ensembl chr17:36,103,827...36,105,621
G
CCL5
C-C motif chemokine ligand 5
increases expression
EXP
beryllium sulfate results in increased expression of CCL5 mRNA
CTD
PMID:16314022
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
G
CCNT1
cyclin T1
increases expression
EXP
beryllium sulfate results in increased expression of CCNT1 mRNA
CTD
PMID:35679967
NCBI chr12:48,688,458...48,716,707
Ensembl chr12:48,688,458...48,716,998
G
CD44
CD44 molecule (IN blood group)
increases expression
EXP
beryllium sulfate results in increased expression of CD44 mRNA
CTD
PMID:16314022
NCBI chr11:35,139,171...35,232,402
Ensembl chr11:35,138,882...35,232,402
G
CD86
CD86 molecule
increases expression
EXP
beryllium sulfate results in increased expression of CD86 protein
CTD
PMID:19665512
NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
G
CDKN1A
cyclin dependent kinase inhibitor 1A
multiple interactions increases expression
EXP
beryllium sulfate promotes the reaction [TP53 protein binds to CDKN1A promoter] beryllium sulfate results in increased expression of CDKN1A mRNA; beryllium sulfate results in increased expression of CDKN1A protein
CTD
PMID:17395767
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
G
CDKN2A
cyclin dependent kinase inhibitor 2A
increases expression
EXP
beryllium sulfate results in increased expression of CDKN2A mRNA; beryllium sulfate results in increased expression of CDKN2A protein
CTD
PMID:17395767
NCBI chr 9:21,967,752...21,995,324
Ensembl chr 9:21,967,752...21,995,301
G
CREB1
cAMP responsive element binding protein 1
multiple interactions
ISO
[beryllium sulfate co-treated with IFNG protein] results in increased expression of CREB1 protein
CTD
PMID:10755711
NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988
G
CRYAA
crystallin alpha A
decreases expression
EXP
beryllium sulfate results in decreased expression of CRYAA mRNA
CTD
PMID:35679967
NCBI chr21:43,169,008...43,172,810
Ensembl chr21:43,169,008...43,172,805
G
CTSL
cathepsin L
increases expression
EXP
beryllium sulfate results in increased expression of CTSL mRNA
CTD
PMID:16314022
NCBI chr 9:87,726,119...87,731,469
Ensembl chr 9:87,724,051...87,731,469
G
CTSV
cathepsin V
increases expression
EXP
beryllium sulfate results in increased expression of CTSV mRNA
CTD
PMID:16314022
NCBI chr 9:97,029,677...97,039,643
Ensembl chr 9:97,029,677...97,156,556
G
CUL9
cullin 9
increases expression decreases expression
EXP
beryllium sulfate results in increased expression of CUL9 mRNA beryllium sulfate results in decreased expression of CUL9 mRNA
CTD
PMID:35679967
NCBI chr 6:43,182,196...43,224,587
Ensembl chr 6:43,182,184...43,224,587
G
CXCL1
C-X-C motif chemokine ligand 1
increases secretion
EXP
beryllium sulfate results in increased secretion of CXCL1 mRNA
CTD
PMID:16314022
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CXCL3
C-X-C motif chemokine ligand 3
increases expression
EXP
beryllium sulfate results in increased expression of CXCL3 mRNA
CTD
PMID:16314022
NCBI chr 4:74,036,589...74,038,689
Ensembl chr 4:74,036,589...74,038,807
G
DDHD2
DDHD domain containing 2
increases expression
EXP
beryllium sulfate results in increased expression of DDHD2 mRNA
CTD
PMID:35679967
NCBI chr 8:38,231,585...38,273,647
Ensembl chr 8:38,225,218...38,275,558
G
EGR2
early growth response 2
increases expression
EXP
beryllium sulfate results in increased expression of EGR2 mRNA
CTD
PMID:16314022
NCBI chr10:62,811,996...62,819,167
Ensembl chr10:62,811,996...62,819,167
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression multiple interactions
ISO
beryllium sulfate results in increased expression of FOS mRNA 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [beryllium sulfate results in increased expression of FOS mRNA]; Dactinomycin inhibits the reaction [beryllium sulfate results in increased expression of FOS mRNA]; Ro 31-8220 inhibits the reaction [beryllium sulfate results in increased expression of FOS mRNA]
CTD
PMID:11568973
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
G
FTH1
ferritin heavy chain 1
multiple interactions decreases expression
EXP
[sodium sulfide results in increased abundance of Hydrogen Sulfide] inhibits the reaction [beryllium sulfate results in decreased expression of FTH1 mRNA]; [sodium sulfide results in increased abundance of Hydrogen Sulfide] inhibits the reaction [beryllium sulfate results in decreased expression of FTH1 protein]; Deferoxamine inhibits the reaction [beryllium sulfate results in decreased expression of FTH1 mRNA]; Deferoxamine inhibits the reaction [beryllium sulfate results in decreased expression of FTH1 protein]; NCOA4 protein affects the reaction [beryllium sulfate results in decreased expression of FTH1 mRNA]; NCOA4 protein affects the reaction [beryllium sulfate results in decreased expression of FTH1 protein] beryllium sulfate results in decreased expression of FTH1 mRNA; beryllium sulfate results in decreased expression of FTH1 protein
CTD
PMID:36843388
NCBI chr11:61,964,285...61,967,634
Ensembl chr11:61,959,718...61,967,634
G
GPX4
glutathione peroxidase 4
decreases expression multiple interactions
EXP
beryllium sulfate results in decreased expression of GPX4 mRNA [sodium bisulfide results in increased abundance of Hydrogen Sulfide] inhibits the reaction [beryllium sulfate results in decreased expression of GPX4 mRNA]; Deferoxamine inhibits the reaction [beryllium sulfate results in decreased expression of GPX4 mRNA]; NCOA4 protein affects the reaction [beryllium sulfate results in decreased expression of GPX4 mRNA]
CTD
PMID:36843388
NCBI chr19:1,103,994...1,106,779
Ensembl chr19:1,103,982...1,106,791
G
HLA-A
major histocompatibility complex, class I, A
increases expression
EXP
beryllium sulfate results in increased expression of HLA-A mRNA
CTD
PMID:16314022
NCBI chr 6:29,942,532...29,945,870
Ensembl chr 6:29,941,260...29,949,572
G
HLA-C
major histocompatibility complex, class I, C
increases expression
EXP
beryllium sulfate results in increased expression of HLA-C mRNA
CTD
PMID:16314022
NCBI chr 6:31,268,749...31,272,092
Ensembl chr 6:31,268,749...31,272,130
G
HLA-DPB1
major histocompatibility complex, class II, DP beta 1
affects binding
EXP
beryllium sulfate binds to HLA-DPB1 protein
CTD
PMID:11423174
NCBI chr 6:33,075,990...33,089,696
Ensembl chr 6:33,075,990...33,089,696
G
HLA-DPB2
major histocompatibility complex, class II, DP beta 2 (pseudogene)
increases response to substance
EXP
HLA-DPB2 protein mutant form results in increased susceptibility to beryllium sulfate
CTD
PMID:16272364
NCBI chr 6:33,112,516...33,129,113
Ensembl chr 6:33,112,516...33,129,084
G
HLA-DRB1
major histocompatibility complex, class II, DR beta 1
increases response to substance increases expression
EXP
HLA-DRB1 protein mutant form results in increased susceptibility to beryllium sulfate beryllium sulfate results in increased expression of HLA-DRB1 mRNA
CTD
PMID:16272364 PMID:16314022
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
G
HNRNPA1
heterogeneous nuclear ribonucleoprotein A1
increases expression
EXP
beryllium sulfate results in increased expression of HNRNPA1 mRNA
CTD
PMID:16314022
NCBI chr12:54,280,726...54,287,087
Ensembl chr12:54,280,193...54,287,088
G
ICAM1
intercellular adhesion molecule 1
multiple interactions increases secretion increases expression
EXP
3,3',4,5'-tetrahydroxystilbene inhibits the reaction [beryllium sulfate results in increased expression of ICAM1 mRNA]; 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [beryllium sulfate results in increased secretion of ICAM1 protein]; Dimethyl Sulfoxide inhibits the reaction [beryllium sulfate results in increased secretion of ICAM1 protein] beryllium sulfate results in increased expression of ICAM1 mRNA; beryllium sulfate results in increased expression of ICAM1 protein
CTD
PMID:18539414
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
IFNG
interferon gamma
increases expression multiple interactions
EXP ISO
beryllium sulfate results in increased expression of IFNG protein [beryllium sulfate co-treated with IFNG protein] results in increased expression of CREB1 protein; [beryllium sulfate co-treated with IFNG protein] results in increased expression of JUN protein; [beryllium sulfate co-treated with IFNG protein] results in increased expression of JUNB protein; [beryllium sulfate co-treated with IFNG protein] results in increased expression of NFKB1 protein; beryllium sulfate promotes the reaction [IFNG protein results in increased expression of TNF protein]
CTD
PMID:10755710 PMID:10755711 PMID:20974702 PMID:33197057
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IL10
interleukin 10
increases expression
EXP
beryllium sulfate results in increased expression of IL10 protein
CTD
PMID:33197057
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL18
interleukin 18
increases expression
EXP
beryllium sulfate results in increased expression of IL18 mRNA; beryllium sulfate results in increased expression of IL18 protein
CTD
PMID:16100009
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
G
IL2
interleukin 2
increases expression
ISO
beryllium sulfate results in increased expression of IL2 mRNA
CTD
PMID:9328138
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
G
IL5
interleukin 5
increases expression
ISO
beryllium sulfate results in increased expression of IL5 mRNA
CTD
PMID:9328138
NCBI chr 5:132,541,445...132,556,815
Ensembl chr 5:132,541,445...132,556,838
G
IL6
interleukin 6
increases expression
ISO
beryllium sulfate results in increased expression of IL6 mRNA
CTD
PMID:9328138
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
ITGB3
integrin subunit beta 3
increases expression
EXP
beryllium sulfate results in increased expression of ITGB3 mRNA
CTD
PMID:16314022
NCBI chr17:47,253,827...47,313,743
Ensembl chr17:47,253,827...47,313,743
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases expression
ISO
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [beryllium sulfate results in increased expression of JUN mRNA]; [beryllium sulfate co-treated with IFNG protein] results in increased expression of JUN protein; Dactinomycin inhibits the reaction [beryllium sulfate results in increased expression of JUN mRNA]; Ro 31-8220 inhibits the reaction [beryllium sulfate results in increased expression of JUN mRNA]
CTD
PMID:10755711 PMID:11568973
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
G
JUNB
JunB proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
[beryllium sulfate co-treated with IFNG protein] results in increased expression of JUNB protein
CTD
PMID:10755711
NCBI chr19:12,791,486...12,793,315
Ensembl chr19:12,791,486...12,793,315
G
KRT4
keratin 4
decreases expression
EXP
beryllium sulfate results in decreased expression of KRT4 mRNA
CTD
PMID:35679967
NCBI chr12:52,806,549...52,814,116
Ensembl chr12:52,806,549...52,814,116
G
LILRB1
leukocyte immunoglobulin like receptor B1
increases expression
EXP
beryllium sulfate results in increased expression of MIR7 mRNA
CTD
PMID:33197057
NCBI chr19:54,616,322...54,638,022
Ensembl chr19:54,617,158...54,638,022
G
LINC00472
long intergenic non-protein coding RNA 472
increases expression decreases expression
EXP
beryllium sulfate results in increased expression of LINC00472 mRNA beryllium sulfate results in decreased expression of LINC00472 mRNA
CTD
PMID:35679967
NCBI chr 6:71,407,864...71,420,745
Ensembl chr 6:71,187,161...71,420,745
G
LINC02108
long intergenic non-protein coding RNA 2108
decreases expression
EXP
beryllium sulfate results in decreased expression of LINC02108 mRNA
CTD
PMID:35679967
NCBI chr 5:58,541,567...58,558,243
Ensembl chr 5:58,541,567...58,558,243
G
MFSD14B
major facilitator superfamily domain containing 14B
decreases expression
EXP
beryllium sulfate results in decreased expression of MFSD14B mRNA
CTD
PMID:35679967
NCBI chr 9:94,374,417...94,461,042
Ensembl chr 9:94,374,569...94,461,042
G
MIR1226
microRNA 1226
increases expression
EXP
beryllium sulfate results in increased expression of MIR1226 mRNA
CTD
PMID:33197057
NCBI chr 3:47,849,555...47,849,629
Ensembl chr 3:47,849,555...47,849,629
G
MIR1306
microRNA 1306
increases expression
EXP
beryllium sulfate results in increased expression of MIR1306 mRNA
CTD
PMID:33197057
NCBI chr22:20,086,058...20,086,142
Ensembl chr22:20,086,058...20,086,142
G
MIR1322
microRNA 1322
increases expression
EXP
beryllium sulfate results in increased expression of MIR1322 mRNA
CTD
PMID:33197057
NCBI chr 8:10,825,373...10,825,443
Ensembl chr 8:10,825,373...10,825,443
G
MIR150
microRNA 150
increases expression
EXP
beryllium sulfate results in increased expression of MIR150 mRNA
CTD
PMID:33197057
NCBI chr19:49,500,785...49,500,868
Ensembl chr19:49,500,785...49,500,868
G
MIR193B
microRNA 193b
increases expression
EXP
beryllium sulfate results in increased expression of MIR193B mRNA
CTD
PMID:33197057
NCBI chr16:14,303,967...14,304,049
Ensembl chr16:14,303,967...14,304,049
G
MIR23B
microRNA 23b
decreases expression
EXP
beryllium sulfate results in decreased expression of MIR23B mRNA
CTD
PMID:33197057
NCBI chr 9:95,085,208...95,085,304
Ensembl chr 9:95,085,208...95,085,304
G
MIR3182
microRNA 3182
increases expression
EXP
beryllium sulfate results in increased expression of MIR3182 mRNA
CTD
PMID:33197057
NCBI chr16:83,508,346...83,508,408
Ensembl chr16:83,508,346...83,508,408
G
MIR3200
microRNA 3200
increases expression
EXP
beryllium sulfate results in increased expression of MIR3200 mRNA
CTD
PMID:33197057
NCBI chr22:30,731,557...30,731,641
Ensembl chr22:30,731,557...30,731,641
G
MIR324
microRNA 324
increases expression
EXP
beryllium sulfate results in increased expression of MIR324 mRNA
CTD
PMID:33197057
NCBI chr17:7,223,297...7,223,379
Ensembl chr17:7,223,297...7,223,379
G
MIR3529
microRNA 3529
increases expression
EXP
beryllium sulfate results in increased expression of MIR3529 mRNA
CTD
PMID:33197057
NCBI chr15:88,611,847...88,611,924
Ensembl chr15:88,611,847...88,611,924
G
MIR363
microRNA 363
increases expression
EXP
beryllium sulfate results in increased expression of MIR363 mRNA
CTD
PMID:33197057
NCBI chr X:134,169,378...134,169,452
Ensembl chr X:134,169,378...134,169,452
G
MIR369
microRNA 369
decreases expression
EXP
beryllium sulfate results in decreased expression of MIR369 mRNA
CTD
PMID:33197057
NCBI chr14:101,065,598...101,065,667
Ensembl chr14:101,065,598...101,065,667
G
MIR3911
microRNA 3911
increases expression
EXP
beryllium sulfate results in increased expression of MIR3911 mRNA
CTD
PMID:33197057
NCBI chr 9:127,690,687...127,690,795
Ensembl chr 9:127,690,687...127,690,795
G
MIR3940
microRNA 3940
decreases expression
EXP
beryllium sulfate results in decreased expression of MIR3940 mRNA
CTD
PMID:33197057
NCBI chr19:6,416,410...6,416,511
Ensembl chr19:6,416,410...6,416,511
G
MIR4482
microRNA 4482
increases expression
EXP
beryllium sulfate results in increased expression of MIR4482 mRNA
CTD
PMID:33197057
NCBI chr10:104,268,336...104,268,405
Ensembl chr10:104,268,336...104,268,405
G
MIR4485
microRNA 4485
increases expression
EXP
beryllium sulfate results in increased expression of MIR4485 mRNA
CTD
PMID:33197057
NCBI chr11:10,508,270...10,508,326
Ensembl chr11:10,508,270...10,508,326
G
MIR4511
microRNA 4511
decreases expression
EXP
beryllium sulfate results in decreased expression of MIR4511 mRNA
CTD
PMID:33197057
NCBI chr15:65,719,246...65,719,332
Ensembl chr15:65,719,246...65,719,332
G
MIR484
microRNA 484
decreases expression
EXP
beryllium sulfate results in decreased expression of MIR484 mRNA
CTD
PMID:33197057
NCBI chr16:15,643,294...15,643,372
Ensembl chr16:15,643,294...15,643,372
G
MIR504
microRNA 504
increases expression
EXP
beryllium sulfate results in increased expression of MIR504 mRNA
CTD
PMID:33197057
NCBI chr X:138,667,711...138,667,793
Ensembl chr X:138,667,711...138,667,793
G
MIR5582
microRNA 5582
increases expression
EXP
beryllium sulfate results in increased expression of MIR5582 mRNA
CTD
PMID:33197057
NCBI chr11:46,753,125...46,753,192
Ensembl chr11:46,753,125...46,753,192
G
MIR573
microRNA 573
increases expression
EXP
beryllium sulfate results in increased expression of MIR573 mRNA
CTD
PMID:33197057
NCBI chr 4:24,520,192...24,520,290
Ensembl chr 4:24,520,192...24,520,290
G
MIR642A
microRNA 642a
decreases expression
EXP
beryllium sulfate results in decreased expression of MIR642 mRNA
CTD
PMID:33197057
NCBI chr19:45,674,928...45,675,024
Ensembl chr19:45,674,928...45,675,024
G
MIR663B
microRNA 663b
decreases expression
EXP
beryllium sulfate results in decreased expression of MIR663B mRNA
CTD
PMID:33197057
NCBI chr 2:132,256,966...132,257,080
Ensembl chr 2:132,256,966...132,257,080
G
MIR877
microRNA 877
increases expression
EXP
beryllium sulfate results in increased expression of MIR877 mRNA
CTD
PMID:33197057
NCBI chr 6:30,584,332...30,584,417
Ensembl chr 6:30,584,332...30,584,417
G
MYC
MYC proto-oncogene, bHLH transcription factor
increases expression
ISO
beryllium sulfate results in increased expression of MYC protein
CTD
PMID:2009323
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
G
NCOA4
nuclear receptor coactivator 4
multiple interactions increases expression
EXP
[sodium sulfide results in increased abundance of Hydrogen Sulfide] inhibits the reaction [beryllium sulfate results in increased expression of NCOA4 mRNA]; [sodium sulfide results in increased abundance of Hydrogen Sulfide] inhibits the reaction [beryllium sulfate results in increased expression of NCOA4 protein]; Deferoxamine inhibits the reaction [beryllium sulfate results in increased expression of NCOA4 mRNA]; Deferoxamine inhibits the reaction [beryllium sulfate results in increased expression of NCOA4 protein]; NCOA4 protein affects the reaction [beryllium sulfate results in decreased expression of FTH1 mRNA]; NCOA4 protein affects the reaction [beryllium sulfate results in decreased expression of FTH1 protein]; NCOA4 protein affects the reaction [beryllium sulfate results in decreased expression of GPX4 mRNA]; NCOA4 protein affects the reaction [beryllium sulfate results in decreased expression of SLC7A11 mRNA]; NCOA4 protein affects the reaction [beryllium sulfate results in increased expression of ACSL4 mRNA]; NCOA4 protein affects the reaction [beryllium sulfate results in increased expression of NCOA4 mRNA]; NCOA4 protein affects the reaction [beryllium sulfate results in increased expression of NCOA4 protein]; NCOA4 protein affects the reaction [beryllium sulfate results in increased expression of PTGS2 mRNA] beryllium sulfate results in increased expression of NCOA4 mRNA; beryllium sulfate results in increased expression of NCOA4 protein
CTD
PMID:36843388
NCBI chr10:46,005,088...46,030,623
Ensembl chr10:46,005,088...46,030,623
G
NEDD8
NEDD8 ubiquitin like modifier
increases expression
EXP
beryllium sulfate results in increased expression of NEDD8 mRNA
CTD
PMID:16314022
NCBI chr14:24,216,857...24,232,367
Ensembl chr14:24,216,857...24,232,367
G
NFKB1
nuclear factor kappa B subunit 1
multiple interactions
ISO
[beryllium sulfate co-treated with IFNG protein] results in increased expression of NFKB1 protein
CTD
PMID:10755711
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
G
NOS2
nitric oxide synthase 2
increases expression
EXP
beryllium sulfate results in increased expression of NOS2 protein
CTD
PMID:33197057
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NOVA1
NOVA alternative splicing regulator 1
increases expression
EXP
beryllium sulfate results in increased expression of NOVA1 mRNA
CTD
PMID:16314022
NCBI chr14:26,443,090...26,598,033
Ensembl chr14:26,443,090...26,598,033
G
PDPK1
3-phosphoinositide dependent protein kinase 1
decreases expression
EXP
beryllium sulfate results in decreased expression of PDPK1 mRNA
CTD
PMID:35679967
NCBI chr16:2,538,021...2,603,188
Ensembl chr16:2,537,979...2,603,188
G
PHF19
PHD finger protein 19
decreases expression
EXP
beryllium sulfate results in decreased expression of PHF19 mRNA
CTD
PMID:35679967
NCBI chr 9:120,855,651...120,904,128
Ensembl chr 9:120,855,651...120,894,896
G
PTGS2
prostaglandin-endoperoxide synthase 2
increases expression multiple interactions
EXP
beryllium sulfate results in increased expression of PTGS2 mRNA; beryllium sulfate results in increased expression of PTGS2 protein [sodium bisulfide results in increased abundance of Hydrogen Sulfide] inhibits the reaction [beryllium sulfate results in increased expression of PTGS2 mRNA]; Deferoxamine inhibits the reaction [beryllium sulfate results in increased expression of PTGS2 mRNA]; NCOA4 protein affects the reaction [beryllium sulfate results in increased expression of PTGS2 mRNA]
CTD
PMID:33197057 PMID:36843388
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
RBM14-RBM4
RBM14-RBM4 readthrough
decreases expression
EXP
beryllium sulfate results in decreased expression of RBM14-RBM4 mRNA
CTD
PMID:35679967
NCBI chr11:66,616,630...66,646,468
Ensembl chr11:66,616,626...66,646,469
G
RHOA
ras homolog family member A
increases expression
EXP
beryllium sulfate results in increased expression of RHOA mRNA
CTD
PMID:16314022
NCBI chr 3:49,359,145...49,411,976
Ensembl chr 3:49,359,139...49,412,998
G
RPL22
ribosomal protein L22
increases expression
EXP
beryllium sulfate results in increased expression of RPL22 mRNA
CTD
PMID:16314022
NCBI chr 1:6,185,020...6,199,595
Ensembl chr 1:6,185,020...6,209,389
G
RPL30
ribosomal protein L30
increases expression
EXP
beryllium sulfate results in increased expression of RPL30 mRNA
CTD
PMID:16314022
NCBI chr 8:98,041,721...98,045,545
Ensembl chr 8:98,024,851...98,046,469
G
RPL37A
ribosomal protein L37a
increases expression
EXP
beryllium sulfate results in increased expression of RPL37A mRNA
CTD
PMID:16314022
NCBI chr 2:216,498,844...216,504,086
Ensembl chr 2:216,498,825...216,579,180
G
RPS7
ribosomal protein S7
increases expression
EXP
beryllium sulfate results in increased expression of RPS7 mRNA
CTD
PMID:16314022
NCBI chr 2:3,575,260...3,580,920
Ensembl chr 2:3,575,260...3,580,920
G
RUNX1
RUNX family transcription factor 1
multiple interactions
EXP
beryllium sulfate promotes the reaction [RUNX1 protein binds to CCL3 promoter]
CTD
PMID:16314022
NCBI chr21:34,787,801...35,049,302
Ensembl chr21:34,787,801...36,004,667
G
SERPINB2
serpin family B member 2
increases expression
EXP
beryllium sulfate results in increased expression of SERPINB2 mRNA
CTD
PMID:16314022
NCBI chr18:63,887,705...63,903,888
Ensembl chr18:63,871,692...63,903,888
G
SFTPD
surfactant protein D
increases expression
EXP
beryllium sulfate results in increased expression of SFTPD mRNA
CTD
PMID:16314022
NCBI chr10:79,937,740...79,982,383
Ensembl chr10:79,937,467...79,982,614
G
SLC7A11
solute carrier family 7 member 11
multiple interactions decreases expression
EXP
[sodium bisulfide results in increased abundance of Hydrogen Sulfide] inhibits the reaction [beryllium sulfate results in decreased expression of SLC7A11 mRNA]; Deferoxamine inhibits the reaction [beryllium sulfate results in decreased expression of SLC7A11 mRNA]; NCOA4 protein affects the reaction [beryllium sulfate results in decreased expression of SLC7A11 mRNA]
CTD
PMID:36843388
NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349
G
TAT
tyrosine aminotransferase
multiple interactions
ISO
beryllium sulfate inhibits the reaction [Hydrocortisone results in increased expression of TAT protein]
CTD
PMID:6120038
NCBI chr16:71,565,660...71,577,092
Ensembl chr16:71,565,660...71,577,092
G
THSD7A
thrombospondin type 1 domain containing 7A
decreases expression increases expression
EXP
beryllium sulfate results in decreased expression of THSD7A mRNA beryllium sulfate results in increased expression of THSD7A mRNA
CTD
PMID:35679967
NCBI chr 7:11,370,365...11,832,198
Ensembl chr 7:11,370,365...11,832,198
G
TMSB4X
thymosin beta 4 X-linked
increases expression
EXP
beryllium sulfate results in increased expression of TMSB4X mRNA
CTD
PMID:16314022
NCBI chr X:12,975,110...12,977,223
Ensembl chr X:12,975,110...12,977,227
G
TNF
tumor necrosis factor
increases expression multiple interactions
ISO EXP
beryllium sulfate results in increased expression of TNF mRNA; beryllium sulfate results in increased expression of TNF protein beryllium sulfate promotes the reaction [IFNG protein results in increased expression of TNF protein]
CTD
PMID:10755710 PMID:10755711 PMID:33197057
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TP53
tumor protein p53
multiple interactions increases expression
EXP
beryllium sulfate promotes the reaction [TP53 protein binds to CDKN1A promoter] beryllium sulfate results in increased expression of TP53 protein
CTD
PMID:17395767 PMID:20974702
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
G
WNT4
Wnt family member 4
increases expression
EXP
beryllium sulfate results in increased expression of WNT4 mRNA
CTD
PMID:16314022
NCBI chr 1:22,117,313...22,143,097
Ensembl chr 1:22,117,313...22,143,969
G
ZNF77
zinc finger protein 77
increases expression
EXP
beryllium sulfate results in increased expression of ZNF77 mRNA
CTD
PMID:16314022
NCBI chr19:2,933,218...2,950,625
Ensembl chr19:2,933,218...2,944,971
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all